| __timestamp | Pharming Group N.V. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14182353 | 31354781 |
| Thursday, January 1, 2015 | 15503028 | 43445817 |
| Friday, January 1, 2016 | 16183585 | 66489820 |
| Sunday, January 1, 2017 | 22382849 | 96886134 |
| Monday, January 1, 2018 | 33038206 | 153793000 |
| Tuesday, January 1, 2019 | 31777040 | 148369000 |
| Wednesday, January 1, 2020 | 41464134 | 151934000 |
| Friday, January 1, 2021 | 67178053 | 198532000 |
| Saturday, January 1, 2022 | 52531000 | 112128000 |
| Sunday, January 1, 2023 | 68914000 | 76192000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Pharming Group N.V. and TG Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, TG Therapeutics, Inc. consistently outpaced Pharming Group N.V. in R&D spending, peaking in 2021 with an investment nearly three times that of Pharming Group. However, Pharming Group showed a remarkable 386% increase in R&D expenses from 2014 to 2023, highlighting its growing focus on innovation.
In 2023, TG Therapeutics reduced its R&D spending by 62% from its 2021 peak, while Pharming Group increased its investment by 31% compared to 2022. This shift suggests a strategic pivot by TG Therapeutics, possibly reallocating resources, while Pharming Group continues to bolster its R&D efforts.
BeiGene, Ltd. vs Pharming Group N.V.: Strategic Focus on R&D Spending
Incyte Corporation or Pharming Group N.V.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Pharming Group N.V.
Pharming Group N.V. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Pharming Group N.V. vs Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Grifols, S.A. vs TG Therapeutics, Inc.
R&D Insights: How TG Therapeutics, Inc. and Xenon Pharmaceuticals Inc. Allocate Funds
Analyzing R&D Budgets: TG Therapeutics, Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: TG Therapeutics, Inc. vs ImmunityBio, Inc.
Research and Development Investment: TG Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.